Jin-Mo Park

Title: Jin-Mo Park: Innovator in Charcot-Marie-Tooth Disease Research

Introduction

Jin-Mo Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the study of Charcot-Marie-Tooth disease. His innovative work has led to the development of a unique animal model that aids in understanding this genetic disorder.

Latest Patents

Jin-Mo Park holds a patent for an "Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier." This invention relates to a HSP27 mutation (S135F) mediated Charcot-Marie-Tooth disease (CMT) animal model. The patent describes a vector expressing the mutant HSP27 protein, wherein the 135 serine is substituted with phenylalanine. This vector has been injected into mouse zygotes, resulting in selected mice that display the Charcot-Marie-Tooth disease phenotype. This animal model is expected to be efficiently used for evaluating potential treatment candidates for Charcot-Marie-Tooth disease.

Career Highlights

Throughout his career, Jin-Mo Park has worked with prominent organizations, including the Samsung Life Public Welfare Foundation and Chong Kun Dang Pharmaceutical Corporation. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Jin-Mo Park has collaborated with notable colleagues, including Yun Tae Kim and Byung-Ok Choi. Their combined efforts have further advanced research in the field of Charcot-Marie-Tooth disease.

Conclusion

Jin-Mo Park's innovative work in developing an animal model for Charcot-Marie-Tooth disease highlights his significant contributions to medical research. His patent and collaborations reflect his commitment to advancing the understanding and treatment of this genetic disorder.